Literature DB >> 10639859

Positron emission tomography for the early diagnosis of dementia.

K Brummel-Smith.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10639859      PMCID： PMC1308732     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  8 in total

Review 1.  Positron emission tomography scanning for the early diagnosis of dementia.

Authors:  G W Small
Journal:  West J Med       Date:  1999 Nov-Dec

Review 2.  Screening for dementia and investigating its causes.

Authors:  A L Siu
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

Review 3.  Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.

Authors:  G W Small; P V Rabins; P P Barry; N S Buckholtz; S T DeKosky; S H Ferris; S I Finkel; L P Gwyther; Z S Khachaturian; B D Lebowitz; T D McRae; J C Morris; F Oakley; L S Schneider; J E Streim; T Sunderland; L A Teri; L E Tune
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

4.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Authors:  S L Rogers; M R Farlow; R S Doody; R Mohs; L T Friedhoff
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

5.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

6.  Combination therapy for early Alzheimer's disease: what are we waiting for?

Authors:  P M Doraiswamy; D C Steffens
Journal:  J Am Geriatr Soc       Date:  1998-10       Impact factor: 5.562

7.  Referral patterns and diagnosis in presenile Alzheimer's disease: implications for general practice.

Authors:  A J Newens; D P Forster; D W Kay
Journal:  Br J Gen Pract       Date:  1994-09       Impact factor: 5.386

8.  A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

Authors:  M J Knapp; D S Knopman; P R Solomon; W W Pendlebury; C S Davis; S I Gracon
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.